Panagora Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.92M | Sell |
351,852
-2,887
| -0.8% | -$40.4K | 0.02% | 336 |
|
|
2025
Q1 | $4.78M | Buy |
354,739
+101,717
| +40% | +$1.37M | 0.02% | 345 |
|
|
2024
Q4 | $4.85M | Buy |
253,022
+84,589
| +50% | +$1.62M | 0.02% | 346 |
|
|
2024
Q3 | $3.83M | Buy |
+168,433
| New | +$3.83M | 0.02% | 395 |
|
|
2020
Q3 | – | Sell |
-151
| Closed | -$3K | – | 2765 |
|
|
2020
Q2 | $3K | Hold |
151
| – | – | ﹤0.01% | 2447 |
|
|
2020
Q1 | $1K | Hold |
151
| – | – | ﹤0.01% | 2456 |
|
|
2019
Q4 | $1K | Hold |
151
| – | – | ﹤0.01% | 2416 |
|
|
2019
Q3 | $2K | Buy |
+151
| New | +$2K | ﹤0.01% | 2377 |
|
|
2018
Q3 | – | Sell |
-383
| Closed | -$37K | – | 2470 |
|
|
2018
Q2 | $37K | Sell |
383
-212
| -36% | -$20.5K | ﹤0.01% | 2097 |
|
|
2018
Q1 | $63K | Hold |
595
| – | – | ﹤0.01% | 1967 |
|
|
2017
Q4 | $93K | Sell |
595
-16
| -3% | -$2.5K | ﹤0.01% | 1899 |
|
|
2017
Q3 | $84K | Sell |
611
-153
| -20% | -$21K | ﹤0.01% | 1930 |
|
|
2017
Q2 | $148K | Buy |
764
+743
| +3,538% | +$144K | ﹤0.01% | 1760 |
|
|
2017
Q1 | $4K | Buy |
+21
| New | +$4K | ﹤0.01% | 2314 |
|